Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Operating Margin (2020 - 2025)

Historic Operating Margin for Rani Therapeutics Holdings (RANI) over the last 5 years, with Q1 2025 value amounting to 6984.3%.

  • Rani Therapeutics Holdings' Operating Margin changed N/A to 6984.3% in Q1 2025 from the same period last year, while for Sep 2025 it was 3727.75%, marking a year-over-year decrease of 77239700.0%. This contributed to the annual value of 5186.19% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Rani Therapeutics Holdings reported Operating Margin of 6984.3% as of Q1 2025.
  • In the past 5 years, Rani Therapeutics Holdings' Operating Margin ranged from a high of 1445.02% in Q2 2023 and a low of 6984.3% during Q1 2025
  • For the 4-year period, Rani Therapeutics Holdings' Operating Margin averaged around 523.54%, with its median value being 384.22% (2023).
  • Per our database at Business Quant, Rani Therapeutics Holdings' Operating Margin skyrocketed by 53818700bps in 2021 and then plummeted by -24916300bps in 2024.
  • Rani Therapeutics Holdings' Operating Margin (Quarter) stood at 268.13% in 2021, then skyrocketed by 487bps to 1036.57% in 2023, then plummeted by -240bps to 1455.06% in 2024, then tumbled by -380bps to 6984.3% in 2025.
  • Its Operating Margin stands at 6984.3% for Q1 2025, versus 1455.06% for Q4 2024 and 1036.57% for Q4 2023.